8-K
Current Report
Candel Therapeutics, Inc. Filed Acc 0001193125-26-059334
Material agreement · Results of operations · Regulation FD disclosure · Other events
- Item 1.01 Entry into a material definitive agreement
- Item 2.02 Results of operations and financial condition
- Item 7.01 Regulation FD disclosure
- Item 8.01 Other events
From the SEC's structured data for this filing
Loading cadl-20260219.htm…